Skip to content

E85.81

Billable

Light chain (AL) amyloidosis

HCC Category Mapping

V28HCC 50Glycogen/Amino-Acid/Other Metabolic Disorders
0.289
V24HCC 23Other Significant Endocrine and Metabolic Disorders
0.230
ESRDHCC 23Other Significant Endocrine and Metabolic Disorders
0.000

What This Code Means

A disease where abnormal light chain proteins accumulate in organs and tissues, causing damage and dysfunction. This is a type of amyloidosis that primarily affects the heart, kidneys, and nervous system.

Coding Tips

  • Specify the organ system affected when documented (cardiac, renal, or neurologic involvement)
  • Light chain amyloidosis is also known as AL amyloidosis; use this code when the diagnosis specifies light chain type

Clinical Significance

Light chain (AL) amyloidosis is the most common form of systemic amyloidosis, caused by misfolded immunoglobulin light chains from an underlying plasma cell dyscrasia. It commonly affects the heart, kidneys, liver, and nervous system, and carries significant morbidity and mortality. Accurate coding is critical for treatment planning with chemotherapy regimens.

Documentation Requirements

  • Confirmed AL amyloidosis diagnosis (tissue biopsy with immunohistochemistry or mass spectrometry showing light chain deposits)
  • Identification of underlying plasma cell disorder (monoclonal gammopathy, multiple myeloma)
  • Affected organ systems and staging (cardiac biomarkers, proteinuria, NT-proBNP, troponin)
  • Free light chain assay results (kappa/lambda ratio)
  • Current treatment regimen (bortezomib-based, daratumumab, stem cell transplant evaluation)
  • Organ response and hematologic response assessment

Commonly Confused Codes

Code Hierarchy

Open E85.81 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.